SynthesisFrontiers in endocrinology2026

Fibroblast growth factor 23 levels and the risk of diabetic kidney disease: a systematic review and meta-analysis.

Xingjia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.